MARINUS PHARMACEUTICALS INC's ticker is and the CUSIP is 56854Q200. A total of 81 filers reported holding MARINUS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,514,958 | -16.7% | 1,306,206 | +12.4% | 0.66% | -19.7% |
| Q2 2023 | $12,626,042 | +52.4% | 1,162,619 | -3.1% | 0.83% | +56.0% |
| Q1 2023 | $8,282,684 | +307.0% | 1,200,389 | +600.6% | 0.53% | +345.4% |
| Q4 2021 | $2,035,000 | +7.3% | 171,338 | +2.8% | 0.12% | +6.2% |
| Q3 2021 | $1,897,000 | -69.5% | 166,711 | -51.8% | 0.11% | -68.7% |
| Q2 2021 | $6,210,000 | +8.3% | 346,160 | -6.5% | 0.36% | +3.8% |
| Q1 2021 | $5,733,000 | +71.5% | 370,351 | +35.2% | 0.34% | +73.4% |
| Q4 2020 | $3,343,000 | – | 274,027 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 2,145,337 | $17,269,963 | 7.70% |
| Bleichroeder LP | 1,872,463 | $15,073,327 | 3.72% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,204,942 | $41,899,783 | 2.26% |
| Opaleye Management Inc. | 584,000 | $4,701,200 | 1.53% |
| Bain Capital Life Sciences Investors, LLC | 1,431,058 | $11,520,017 | 1.29% |
| Cormorant Asset Management, LP | 2,625,000 | $21,131,250 | 1.23% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 290,000 | $2,337,400 | 0.79% |
| Ikarian Capital, LLC | 746,069 | $6,005,856 | 0.72% |
| Eventide Asset Management | 4,529,997 | $36,466,476 | 0.66% |
| Altium Capital Management LP | 125,033 | $1,006,516 | 0.52% |